Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05746507 · ClinicalTrials.gov registry record · NA
Night Respite for Postpartum Mothers With SUD
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT05746507: Completed NA study, sponsored by Massachusetts General Hospital.
NCT05746507 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05746507, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
This single arm pilot feasibility study will evaluate the implementation of overnight infant respite care and parenting skills to mothers with substance use disorders in the early postpartum period residing in residential substance use disorder treatment programs.
Interventions
- BEHAVIORAL Night Respite Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2022-12-20 |
| Est. Completion | 2025-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05746507
The ClinicalTrials.gov registry entry for NCT05746507 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Night Respite Care is the first listed.
NCT05746507 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05746507 about?
NCT05746507 is a clinical study titled "Night Respite for Postpartum Mothers With SUD". This single arm pilot feasibility study will evaluate the implementation of overnight infant respite care and parenting skills to mothers with substance use disorders in the early postpartum period residing in residential substance use disorder treatment programs.
What is the current status of trial NCT05746507?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2022-12-20. Estimated completion is 2025-04-30.
What interventions are being tested in trial NCT05746507?
The interventions under investigation include: Night Respite Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT05746507?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.